How do I find recruiting Acute Lymphoblastic Leukemia clinical trials?

Browse the actively recruiting Acute Lymphoblastic Leukemia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.

Are Acute Lymphoblastic Leukemia clinical trials free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

Who can take part in a Acute Lymphoblastic Leukemia clinical trial?

Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.

Acute Lymphoblastic Leukemia Clinical Trials

Acute Lymphoblastic Leukemia clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for acute Lymphoblastic Leukemia. Corterve aggregates actively recruiting Acute Lymphoblastic Leukemia studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.

Browse all Acute Lymphoblastic Leukemia trials Take the assessment

Recruiting Acute Lymphoblastic Leukemia studies

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
NCT06317662PHASE2National Cancer Institute (NCI)Acute Leukemia of Ambiguous LineageBirmingham, Alabama
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
NCT03739814PHASE2National Cancer Institute (NCI)B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeBirmingham, Alabama
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
NCT05621291NANational Cancer Institute (NCI)B-AllLos Angeles, California
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
NCT07572136PHASE1National Cancer Institute (NCI)B-AllBethesda, Maryland
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
NCT00501826PHASE2M.D. Anderson Cancer CenterT Acute Lymphoblastic LeukemiaHouston, Texas
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103PHASE1, PHASE2Merck Sharp & Dohme LLCB-cell Acute Lymphoblastic LeukemiaLos Angeles, California
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
NCT06124157PHASE2National Cancer Institute (NCI)B Acute Lymphoblastic LeukemiaBirmingham, Alabama
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
NCT06398457EARLY_PHASE1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsHematologic MalignancyBaltimore, Maryland
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
NCT06173518PHASE1Autolus LimitedRelapsed or Refractory B Cell Acute Lymphoblastic LeukemiaAurora, Colorado
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
NCT07223021PHASE3Memorial Sloan Kettering Cancer CenterB-cell Acute Lymphoblastic LeukemiaNew York, New York
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
NCT03150693PHASE3Alliance for Clinical Trials in OncologyB Acute Lymphoblastic LeukemiaBirmingham, Alabama
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069Alliance for Clinical Trials in OncologyAcute Lymphoblastic LeukemiaAnchorage, Alaska

See all 132 recruiting trials →

Acute Lymphoblastic Leukemia trials by state

Acute Lymphoblastic Leukemia trials by metro

Frequently asked questions

How do I find recruiting Acute Lymphoblastic Leukemia clinical trials?: Browse the actively recruiting Acute Lymphoblastic Leukemia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
Are Acute Lymphoblastic Leukemia clinical trials free to join?: Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
Who can take part in a Acute Lymphoblastic Leukemia clinical trial?: Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.